CALML5 and breast carcinoma: For the breast cancer NGS study, we deliberately selected TP53, ADCY1, IL17D, TNF, CALML5, and TAS1R3 as the reference for p53, Estrogen, Jak-STAT, mTOR, oocyte meiosis, and taste transduction pathways, respectively.